These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25109224)

  • 1. Differential attrition in health behaviour change trials: a systematic review and meta-analysis.
    Crutzen R; Viechtbauer W; Spigt M; Kotz D
    Psychol Health; 2015 Jan; 30(1):122-34. PubMed ID: 25109224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No differential attrition was found in randomized controlled trials published in general medical journals: a meta-analysis.
    Crutzen R; Viechtbauer W; Kotz D; Spigt M
    J Clin Epidemiol; 2013 Sep; 66(9):948-54. PubMed ID: 23790724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attrition rates in trials for adolescents and young adults at clinical high-risk for psychosis: A systematic review and meta-analysis.
    Farris MS; Devoe DJ; Addington J
    Early Interv Psychiatry; 2020 Oct; 14(5):515-527. PubMed ID: 31422583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta analysis of differential attrition between active and control arms in randomized controlled trials of lifestyle interventions in chronic disease.
    W B; A S; P J; Ga J; Tj W
    BMC Med Res Methodol; 2021 Jun; 21(1):122. PubMed ID: 34126934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes.
    Heneghan C; Perera R; Ward A A; Fitzmaurice D; Meats E; Glasziou P
    BMC Med Res Methodol; 2007 May; 7():18. PubMed ID: 17474976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.
    Leon AC; Mallinckrodt CH; Chuang-Stein C; Archibald DG; Archer GE; Chartier K
    Biol Psychiatry; 2006 Jun; 59(11):1001-5. PubMed ID: 16503329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrolment-latency in randomized behavior change trials: individual participant data meta-analysis showed association with attrition but not effect-size.
    Kypri K; Bowe SJ; Karlsson N; McCambridge J
    J Clin Epidemiol; 2020 Feb; 118():55-59. PubMed ID: 31706962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials.
    Heo M
    J Biopharm Stat; 2014; 24(3):507-22. PubMed ID: 24697555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attrition in trials evaluating complex interventions for schizophrenia: Systematic review and meta-analysis.
    Szymczynska P; Walsh S; Greenberg L; Priebe S
    J Psychiatr Res; 2017 Jul; 90():67-77. PubMed ID: 28231496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta-epidemiological study.
    Overgaard SH; Moos CM; Ioannidis JPA; Luta G; Berg JI; Nielsen SM; Andersen V; Christensen R
    Res Synth Methods; 2024 Jul; 15(4):561-575. PubMed ID: 38351627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early participant attrition from clinical trials: role of trial design and logistics.
    Siddiqi AE; Sikorskii A; Given CW; Given B
    Clin Trials; 2008; 5(4):328-35. PubMed ID: 18697847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to participant retention in knee osteoarthritis clinical trials: a systematic review.
    Koog YH; Gil M; We SR; Wi H; Min BI
    Semin Arthritis Rheum; 2013 Feb; 42(4):346-54. PubMed ID: 22920237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the MORECare guidelines on reporting of attrition in palliative care research populations appropriate? A systematic review and meta-analysis of randomised controlled trials.
    Oriani A; Dunleavy L; Sharples P; Perez Algorta G; Preston NJ
    BMC Palliat Care; 2020 Jan; 19(1):6. PubMed ID: 31918702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating interventions with differential attrition: the importance of nonresponse mechanisms and use of follow-up data.
    Graham JW; Donaldson SI
    J Appl Psychol; 1993 Feb; 78(1):119-28. PubMed ID: 8449850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for expected attrition in the planning of community intervention trials.
    Taljaard M; Donner A; Klar N
    Stat Med; 2007 Jun; 26(13):2615-28. PubMed ID: 17068842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the risk of bias in health behaviour change trials: improving trial design, reporting or bias assessment criteria? A review and case study.
    de Bruin M; McCambridge J; Prins JM
    Psychol Health; 2015 Jan; 30(1):8-34. PubMed ID: 25112431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalogue of bias: attrition bias.
    Nunan D; Aronson J; Bankhead C
    BMJ Evid Based Med; 2018 Feb; 23(1):21-22. PubMed ID: 29367321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.